

A provider's guide to helping patients afford Benzonatate. Learn about discount cards, generic pricing, therapeutic alternatives, and building cost conversations into care.
Benzonatate is one of the most affordable prescription cough suppressants on the market. As a Tier 1 generic on most formularies, it should be a straightforward fill. But "affordable" is relative — and even small out-of-pocket costs can create barriers for patients who are uninsured, underinsured, or managing tight budgets during an illness.
A patient who shows up at the pharmacy and sees a $46–$65 cash price for 30 capsules may walk away without filling the prescription. That's a missed treatment opportunity. As a provider, a brief conversation about cost — or a simple recommendation to use a discount card — can make the difference between a filled prescription and an abandoned one.
This guide covers the savings tools, pricing landscape, and conversation strategies that can help your patients access Benzonatate affordably.
Understanding the pricing landscape helps you anticipate patient concerns:
The key insight: the cash price varies dramatically between pharmacies — sometimes by 10x or more for the same medication. Patients who don't shop around or use discount tools pay far more than necessary.
Because Benzonatate is exclusively available as a generic (the brand Tessalon Perles has been largely discontinued), there are no manufacturer savings programs or copay cards available. This is different from branded medications where the manufacturer may subsidize patient costs.
The absence of manufacturer programs makes third-party discount cards the primary savings mechanism for uninsured patients.
These are the most impactful tools you can recommend to patients paying out of pocket. They're free to use and accepted at most major pharmacies:
You don't need to become a pharmacy benefits expert. A simple, scripted recommendation works:
"Benzonatate is very affordable — usually under $10 with a free discount card. Before you go to the pharmacy, search 'GoodRx Benzonatate' on your phone and show the coupon when you pick it up. It works even without insurance."
Consider having your medical assistants or front desk staff share this tip during checkout, or include it on after-visit summaries.
For patients with significant financial hardship, there are broader assistance resources — though Benzonatate-specific programs don't exist due to its generic-only status:
For a patient-facing version of these resources, you can direct them to our guide: How to Save Money on Benzonatate.
Benzonatate itself is already the most cost-effective prescription antitussive option. However, if a patient can't access or afford it, consider these therapeutic alternatives:
In most cases, if cost is the only barrier, helping the patient access Benzonatate through a discount card is preferable to switching to an alternative medication.
For a patient-facing comparison, see: Alternatives to Benzonatate.
Research consistently shows that patients don't bring up medication cost on their own — even when it causes them to skip doses or abandon prescriptions entirely. Proactive cost conversations improve adherence.
If a patient reports not filling their Benzonatate prescription due to cost:
Benzonatate is one of the most affordable prescription medications you'll prescribe. But "affordable" still requires the patient to know their options. A 30-second recommendation — "Use a GoodRx coupon and it'll be under $10" — can eliminate cost as a barrier and ensure your patients actually fill and take the medication you've prescribed.
For tools to help your patients find Benzonatate in stock and at the best price, visit Medfinder for Providers.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.